Prove2 study: Treatment of chronic hepatitis C with telaprevir (TVR)in combination with peginterferon-alfa-2a with or without ribavirin, interim analysis results

被引:0
|
作者
Hezode, Christophe
Ferenci, Peter
Dusheiko, Geoffrey M.
Tran, Albert
Grange, Jean-Didier
Mathurin, Philippe
Schmidt, Wolfgang E.
Diepolder, Helmut
Marcellin, Patrick
Wedemeyer, Heiner
Forestier, Nicole
Mangels, Wendy
Gharakhanian, Shahin
Kauffman, Robert S.
Alam, John
Pawlotsky, Jean-Michel
Zeuzem, Stefan
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A755 / A755
页数:1
相关论文
共 50 条
  • [31] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C
    Rakov, NE
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03): : 259 - 260
  • [32] Cost-effectiveness of peginterferon-alfa-2a (40 kd) associated with ribavirin in the treatment of patients with chronic hepatitis C, genotypes 2 and 3 in Brazil
    Parana, R.
    Sette, H.
    Pessoa, M.
    Crespo, D.
    Barros, F.
    Saggia, M. G.
    Santos, E. A.
    Simoes, R.
    VALUE IN HEALTH, 2007, 10 (06) : A438 - A439
  • [33] ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: FINAL RESULTS OF STUDY C209
    Foster, G. R.
    Hezode, C.
    Bronowicki, J. -P.
    Carosi, G.
    Weiland, O.
    Verlinden, L.
    van Heeswijk, R.
    Van Baelen, B.
    Picchio, G.
    Beaumont-Mauviel, M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S27 - S27
  • [34] VX-222/TELAPREVIR IN COMBINATION WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS TREATED FOR 12 WEEKS: ZENITH STUDY, SVR12 INTERIM ANALYSIS
    Nelson, David R.
    Gane, Edward J.
    Jacobson, Ira M.
    Di Bisceglie, Adrian M.
    Alves, Katia
    Koziel, Margaret J.
    De Souza, Cynthia
    Kieffer, Tara L.
    George, Shelley
    Rosario, Maria
    Kauffman, Robert S.
    Sulkowski, Mark S.
    HEPATOLOGY, 2011, 54 : 1435A - 1435A
  • [35] Telaprevir in Combination with Peginterferon and Ribavirin In Genotype 1 HCV Treatment-Naive Patients, Prior Relapsers and Prior Non-Responders: Pooled Analysis Of PROVE 1, PROVE2, PROVE3 and Study 107
    Shiffman, Mitchell
    Berg, Thomas
    Muir, Andrew
    McHutchison, John
    Pawlotsky, Jean-Michel
    Zeuzem, Stefan
    Bengtsson, Leif
    Adda, Nathalie
    George, Shelley
    Kauffman, Robert
    Poordad, Fred
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S102 - S102
  • [36] Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment:: 24-week interim results of a pilot study
    Poo, JL
    Sánchez-Avila, F
    Kershenobich, D
    García-Samper, X
    Gongora, J
    Uribe, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (12) : S79 - S81
  • [37] Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment:: 24-week interim results of a pilot study
    Poo, JL
    Sánchez-Avila, F
    Kershenobich, D
    García-Samper, X
    Gongora, J
    Uribe, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 : S79 - S81
  • [38] First Real-life data of triple therapy with telaprevir (TVR) and boceprevir (BOC) in combination with peginterferon-alfa-2a (PEG) plus ribavirin (RBV) in patients infected with chronic hepatitis C (CHC), genotype 1 in a non-interventional study (PAN) in Germany
    Forestier, Nicole
    Moog, Gero
    Lutz, Thomas
    Leuschner, Maria S.
    Christensen, Stefan
    Schott, Eckart
    Kallinowski, Birgit
    Buggisch, Peter
    Hueppe, Dietrich
    Alshuth, Ulrich
    Milicic-Ouakili, Kerstin
    Mauss, Stefan
    HEPATOLOGY, 2012, 56 : 1038A - 1038A
  • [39] THE COST-EFFECTIVENESS OF TELAPREVIR (TVR) IN COMBINATION WITH PEGYLATED INTERFERON-ALFA AND RIBAVIRIN (PR) FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS
    Curtis, S.
    Cure, S.
    Gavart, S.
    Dearden, L.
    Fleischmann, J.
    Ouwens, M.
    Lee, S.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S434 - S434
  • [40] Peginterferon alfa-2b and ribavirin for treatment-refractory chronic hepatitis C
    Krawitt, EL
    Ashikaga, T
    Gordon, SR
    Ferrentino, N
    Ray, MA
    Lidofsky, SD
    JOURNAL OF HEPATOLOGY, 2005, 43 (02) : 243 - 249